Related Experiment Video

Updated: Jan 21, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Updated management for patients with cardiovascular disease and diabetes

Joy Dugan1, Amy Butts, Billy St John Collins

  • 1Joy Dugan, Amy Butts, Billy St. John Collins, and Parmjeet S. Saini are members of the American Diabetes Association's Primary Care Advisory Group. Ms. Butts is an endocrinology PA for Wheeling Hospital in Wellsburg, W.Va. Dr. Collins is an associate clinical investigator in the cardiovascular branch of the National Heart, Lung & Blood Institute. Dr. Saini is a regulatory officer in the Northeast division of the survey and certification branch of the Centers for Medicare and Medicaid Services. Dr. Dugan is an associate program director at Touro University California Joint MSPAS/MPH Program. Sarah Bradley is director of professional engagement and collaborations for the American Diabetes Association in Arlington, Va. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|July 27, 2019
PubMed

Insights

Atherosclerotic cardiovascular disease (ASCVD) is a major health risk for people with diabetes. New guidelines offer updated recommendations for managing hypertension, lipids, heart failure, and coronary heart disease to improve patient outcomes.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) is the primary cause of death and illness in diabetic patients.
  • Effective management of cardiovascular risk factors is crucial for this population.

Purpose of the Study:

  • To summarize key updates in the latest American Diabetes Association (ADA) guidelines concerning cardiovascular disease (CVD) and risk management in patients with diabetes.
  • To highlight essential information for clinicians regarding primary and secondary ASCVD prevention.

Main Methods:

  • Review of the most recent American Diabetes Association (ADA) guidelines.
  • Focus on updates related to hypertension, lipid management, heart failure, and coronary heart disease.
  • Emphasis on ASCVD prevention strategies within the context of diabetes care.

Main Results:

  • The 2023 ADA guidelines incorporate significant new information on managing cardiovascular risk factors in diabetes.
  • The guidelines emphasize both primary and secondary prevention of ASCVD.
  • Endorsement by the American College of Cardiology signifies a unified approach to cardiovascular care in diabetes.

Conclusions:

  • Clinicians should be aware of the updated ADA guidelines for optimal ASCVD risk management in diabetic patients.
  • Implementing these guidelines is critical for reducing morbidity and mortality associated with ASCVD in diabetes.
  • The integration of cardiology recommendations strengthens the focus on cardiovascular health in diabetes management.

More Related Videos

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies10:11

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies

Published on: October 22, 2014

19.6K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
875
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
423
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
461
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
448
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
299